ARKG vs. FHLC
ARKG (ARK Genomic Revolution Multi-Sector ETF) and FHLC (Fidelity MSCI Health Care Index ETF) are both Health & Biotech Equities funds. ARKG is actively managed, while FHLC is passively managed. Over the past 10 years, ARKG returned 7.22%/yr vs 9.14%/yr for FHLC. A 0.62 correlation means they provide meaningful diversification when combined. ARKG charges 0.75%/yr vs 0.08%/yr for FHLC.
Performance
ARKG vs. FHLC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ARKG achieves a 17.09% return, which is significantly higher than FHLC's -3.90% return. Over the past 10 years, ARKG has underperformed FHLC with an annualized return of 7.22%, while FHLC has yielded a comparatively higher 9.14% annualized return.
ARKG
- 1D
- -0.24%
- 1M
- 10.92%
- YTD
- 17.09%
- 6M
- 10.02%
- 1Y
- 53.35%
- 3Y*
- 0.67%
- 5Y*
- -15.72%
- 10Y*
- 7.22%
FHLC
- 1D
- 0.82%
- 1M
- 1.50%
- YTD
- -3.90%
- 6M
- -4.11%
- 1Y
- 14.43%
- 3Y*
- 6.14%
- 5Y*
- 4.50%
- 10Y*
- 9.14%
ARKG vs. FHLC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ARKG ARK Genomic Revolution Multi-Sector ETF | 17.09% | 23.04% | -28.24% | 16.22% | -53.90% | -33.92% | 180.40% | 44.00% | -1.26% | 46.61% |
FHLC Fidelity MSCI Health Care Index ETF | -3.90% | 15.42% | 2.48% | 2.58% | -5.55% | 20.39% | 18.13% | 21.94% | 4.71% | 23.34% |
Correlation
The correlation between ARKG and FHLC is 0.51, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.51 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.53 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.57 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.61 |
Correlation (All Time) Calculated using the full available price history since Nov 3, 2014 | 0.62 |
The correlation between ARKG and FHLC shifts across timeframes, from 0.51 (1 year) to 0.62 (all time), reflecting how their relationship changes across market environments.
ARKG vs. FHLC - Sectors Allocation Comparison
Sectors
ARKG
FHLC
Healthcare
Financial Services
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Industrials
-
Real Estate
-
-
Technology
-
Utilities
-
-
Healthcare
ARKG
FHLC
Financial Services
ARKG
FHLC
Basic Materials
ARKG
-
FHLC
-
Communication Services
ARKG
-
FHLC
-
Consumer Cyclical
ARKG
-
FHLC
-
Consumer Defensive
ARKG
-
FHLC
-
Energy
ARKG
-
FHLC
-
Industrials
ARKG
-
FHLC
Real Estate
ARKG
-
FHLC
-
Technology
ARKG
-
FHLC
Utilities
ARKG
-
FHLC
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ARKG vs. FHLC — Risk / Return Rank
ARKG
FHLC
ARKG vs. FHLC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ARK Genomic Revolution Multi-Sector ETF (ARKG) and Fidelity MSCI Health Care Index ETF (FHLC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ARKG | FHLC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.29 | ||
| Sortino ratioReturn per unit of downside risk | +0.41 | ||
| Omega ratioGain probability vs. loss probability | 1.22 | 1.18 | +0.04 |
| Calmar ratioReturn relative to maximum drawdown | 1.95 | 1.40 | +0.55 |
| Martin ratioReturn relative to average drawdown | 4.67 | 3.52 | +1.15 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ARKG | FHLC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.31 | 1.01 | +0.29 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.35 | 0.30 | -0.65 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.18 | 0.55 | -0.37 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.13 | 0.61 | -0.47 |
Drawdowns
ARKG vs. FHLC - Drawdown Comparison
The maximum ARKG drawdown since its inception was -83.59%, which is greater than FHLC's maximum drawdown of -28.76%. Use the drawdown chart below to compare losses from any high point for ARKG and FHLC.
Loading charts...
Drawdown Indicators
| ARKG | FHLC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -83.59% | -28.76% | -54.83% |
Max Drawdown (1Y)Largest decline over 1 year | -27.51% | -10.38% | -17.13% |
Max Drawdown (3Y)Largest decline over 3 years | -51.96% | -16.87% | -35.09% |
Max Drawdown (5Y)Largest decline over 5 years | -80.18% | -17.73% | -62.45% |
Max Drawdown (10Y)Largest decline over 10 years | -83.59% | -28.76% | -54.83% |
Current DrawdownCurrent decline from peak | -69.65% | -6.96% | -62.69% |
Average DrawdownAverage peak-to-trough decline | -35.87% | -5.19% | -30.68% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.46% | 4.11% | +7.35% |
Volatility
ARKG vs. FHLC - Volatility Comparison
ARK Genomic Revolution Multi-Sector ETF (ARKG) has a higher volatility of 11.90% compared to Fidelity MSCI Health Care Index ETF (FHLC) at 4.05%. This indicates that ARKG's price experiences larger fluctuations and is considered to be riskier than FHLC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ARKG | FHLC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.90% | 4.05% | +7.85% |
Volatility (6M)Calculated over the trailing 6-month period | 28.77% | 10.11% | +18.66% |
Volatility (1Y)Calculated over the trailing 1-year period | 41.12% | 14.33% | +26.79% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 45.61% | 14.97% | +30.64% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 41.12% | 16.81% | +24.31% |
ARKG vs. FHLC - Expense Ratio Comparison
ARKG has a 0.75% expense ratio, which is higher than FHLC's 0.08% expense ratio.
Dividends
ARKG vs. FHLC - Dividend Comparison
ARKG has not paid dividends to shareholders, while FHLC's dividend yield for the trailing twelve months is around 1.43%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ARKG ARK Genomic Revolution Multi-Sector ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.62% | 0.85% | 3.14% | 0.82% | 1.34% | 0.00% | 0.00% |
FHLC Fidelity MSCI Health Care Index ETF | 1.43% | 1.40% | 1.51% | 1.40% | 1.30% | 1.16% | 1.45% | 1.18% | 1.38% | 1.38% | 1.40% | 2.07% |
Frequently Asked Questions
ARKG and FHLC have a correlation of 0.51, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ARKG has higher volatility (11.90%) compared to FHLC (4.05%). In terms of maximum drawdown, ARKG dropped -83.59% vs FHLC's -28.76%.
On 10-year performance, FHLC leads with 9.14% vs 7.22% for ARKG. On fees, FHLC is cheaper at 0.08% per year. On volatility, FHLC has been the lower-risk option at 4.05%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, FHLC has performed better with a 9.14% return vs 7.22%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
FHLC is cheaper with a 0.08% expense ratio, compared with 0.75% for ARKG.
FHLC has the higher dividend yield at 1.43%, compared with 0.00% for ARKG.
They also come from different issuers: ARK and Fidelity. Their fees differ too: 0.75% for ARKG and 0.08% for FHLC.
ARKG currently has the higher Sharpe Ratio (1.31 vs 1.01), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ARKG and FHLC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer